TEL AVIV, Israel and NEW YORK, Jan. 22, 2024 /PRNewswire/ — BioCatch, the global leader in digital fraud and money laundering detection and response powered by behavioral biometric intelligence, today announced preliminary results for its fiscal year 2023, achieving 49% annual ARR growth after closing the largest sales quarter in the company’s history, on the heels of crossing the $100m ARR milestone in early November 2023.
Read more here.
![[Aria Pharmaceuticals in Drug Target Review] An equal seat at the table for AI in pharmaceutical discovery](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
